ablinc 产品代理
ablinc 产品代理
ABL拥有位于美国和欧洲的cGMP设施，能够利用一次性生物反应器平台和其他一次性技术为蛋白质和病毒生产提供全面的开发和制造支持。ABL为我们的客户提供全面集成的解决方案，包括细胞系和工艺开发、GMP制造、QC放行测试和QA/监管支持。
ABL的合同研究团队在免疫分析、开发定制分析和小组以支持人类临床试验和临床前动物研究方面拥有数十年的经验。我们经常与客户合作，设计和运行免疫原性研究、生物标记物分析和其他评估，以更好地了解尖端疗法的影响：作用机制、保护相关性、药代动力学/药效学研究和其他关键的安全性和有效性数据。
ABL是Mérieux研究所（Institut Mérieux）的子公司，该研究所是一个致力于为全球医学和公共卫生服务的全球性组织。
Gene Therapies
Oncolytic Vectors
Vaccines
Immunotherapies
ABL is a biotech corporation with headquarters located in Rockville, MD providing contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. ABL combines its expertise in translational science together with operational excellence to solve the challenging product development problems that are often faced by our clients as they bring their life-changing technologies to the world.
With cGMP facilities located in the U.S. and Europe, ABL is well positioned to provide comprehensive development and manufacturing support for protein and virus production utilizing single-use bioreactor platforms and other disposable technologies. ABL provides our clients with a fully integrated solution that includes cell line and process development, GMP manufacturing, QC release testing and QA/Regulatory support.
ABL’s contract research teams have decades of experience with immunoassays, developing custom assays and panels to support human clinical trials and preclinical animal studies. We routinely work with clients to design and run immunogenicity studies, biomarker analyses and other evaluations to better understand the impact of cutting-edge therapies: the mechanism of action, correlates of protection, pharmacokinetic/pharmacodynamics studies and other critical safety and efficacy data.
ABL is a subsidiary of the Institut Mérieux, a global organization committed to serving medicine and public health across the globe.
